CLSI M27M44S
Performance Standards for Antifungal Susceptibility Testing of Yeasts
This document provides updated minimal inhibitory concentration (MIC), zone diameter, and quality control (QC) tables for use with CLSI antifungal susceptibility testing standards, M27 and M44. These updates ensure laboratories have the most current breakpoints and guidelines for accurate and standardized antifungal susceptibility testing.
This document replaces the previous edition of the document, M60-Ed2, and has been recoded to align with the documents it is a supplement to.
{{FormatPrice(currentPrice)}}
Free
{{FormatPrice(nonMemberPrice)}} List PriceClinical and Laboratory Standards Institute document M27M44S—Performance Standards for Antifungal Susceptibility Testing of Yeasts includes minimal inhibitory concentration, zone diameter, and quality control tables developed following the guidance in CLSI documents M27 and M44. The data in the tables are valid only when the methodologies in CLSI documents M27 and M44 are followed. Users should replace previously published tables with these new tables. Changes in the tables since the previous edition was published appear in boldface type.
This document replaces the previous edition of the approved document, M60-Ed2, published in 2020. Several changes were made in this edition.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.
This document is available in electronic format only.
M27-S1: May 2004
M27-S2: April 2005
M27-S3: April 2008
M27-S4: December 2012
M44-S1: January 2006
M44-S2: August 2007
M44-S3: August 2009
M60-Ed1: November 2017
M60-Ed2: June 2020
Clinical and Laboratory Standards Institute document M27M44S—Performance Standards for Antifungal Susceptibility Testing of Yeasts includes minimal inhibitory concentration, zone diameter, and quality control tables developed following the guidance in CLSI documents M27 and M44. The data in the tables are valid only when the methodologies in CLSI documents M27 and M44 are followed. Users should replace previously published tables with these new tables. Changes in the tables since the previous edition was published appear in boldface type.
This document replaces the previous edition of the approved document, M60-Ed2, published in 2020. Several changes were made in this edition.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.
This document is available in electronic format only.
M27-S1: May 2004
M27-S2: April 2005
M27-S3: April 2008
M27-S4: December 2012
M44-S1: January 2006
M44-S2: August 2007
M44-S3: August 2009
M60-Ed1: November 2017
M60-Ed2: June 2020